Skinvisible, Inc. (SKVI): EBITDA
-$476.1K
Year ended 2025-12-31
-$438.7K
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$476.1K | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$569.2K | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$471.6K | n/m | 2025-04-14, From 2023-01-01 |
| 2022-12-31 | -$219.7K | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $206.0K | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$221.6K | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$500.2K | n/m | 2021-04-15, From 2019-01-01 |
| 2018-12-31 | -$559.0K | n/m | 2020-05-14, From 2018-01-01 |
| 2017-12-31 | -$309.7K | n/m | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | -$784.1K | n/m | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | -$1.02M | n/m | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | -$1.13M | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$722.3K | n/m | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$1.27M | n/m | 2014-04-11, From 2012-01-01 |
| 2011-12-31 | -$1.17M | n/m | 2013-04-16, From 2011-01-01 |
| 2010-12-31 | -$758.3K | n/a | 2012-11-19, From 2010-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$476.1K | n/m |
| Talphera, Inc. (TLPH) | 2024-12-31 | -$15.25M | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$3.14M | n/m |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | -$257.87M | n/m |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | -$12.12M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$72.58M | n/m |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | -$57.37M | n/m |
| One World Products, Inc. (OWPC) | 2024-12-31 | -$1.87M | n/m |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | -$23.54M | n/m |
Compare SKVI, TLPH, IBO, LYEL side by side · Screen every company in Pharmaceutical Preparations ↗